China is rapidly overtaking the US in global oncology clinical trials, accounting for more than half of late-stage study activity by 2025.

J&J's MonumenTAL-6 results add to the growing body of evidence touting Talvey and Tecvayli’s use in earlier multiple myeloma treatment lines.

Eli Lilly is set for another win in the glucagon-like peptide-1 (GLP-1) sector as its triple-g agonist, retatrutide, has succeeded in type 2 diabetes and obesity. Marking the four ...

The funds will help Crystalys progress its clinical-stage development efforts and commercialisation plans for its gout drug, dotinurad.

Devonian Health Group has received authorisation from Health Canada for its CTA to begin a Phase II/III study of Thykamine cream to treat mild-to-moderate atopic dermatitis in paediatric patients.

Phase I accounts for approximately 43.6% of all Alzheimer’s disease trials, highlighting a strong influx of early stage candidates entering the pipeline. Credit: Only_NewPhoto via Shutterstock.com.

The Phase III trial failed to meet its co-primary endpoints or any of its key secondary endpoints. Credit: Ton Photographer 4289 / Shuttertock.com Kolon TissueGene’s stock has dropped after a Phase ...

Agios has decided to terminate the development of its sickle cell disease candidate, tebapivat based on its lack of differentiation from approved therapies. Credit: Krot_Studio / Shutterstock.com.

Bayer and Henry Ford Health intend to work together throughout clinical trials. Credit: Stock-Asso / Shutterstock.com. Bayer and Henry Ford Health have entered a strategic research partnership aimed ...

GSK will discontinue camlipixant’s late-stage RCC programme, though it will continue the drug’s development in two forms of IBS.